1. Home
  2. ELVN vs FWRG Comparison

ELVN vs FWRG Comparison

Compare ELVN & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • FWRG
  • Stock Information
  • Founded
  • ELVN 2016
  • FWRG 1983
  • Country
  • ELVN United States
  • FWRG United States
  • Employees
  • ELVN N/A
  • FWRG N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • FWRG Restaurants
  • Sector
  • ELVN Health Care
  • FWRG Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • FWRG Nasdaq
  • Market Cap
  • ELVN 1.2B
  • FWRG 970.4M
  • IPO Year
  • ELVN 2020
  • FWRG 2021
  • Fundamental
  • Price
  • ELVN $18.43
  • FWRG $16.65
  • Analyst Decision
  • ELVN Strong Buy
  • FWRG Strong Buy
  • Analyst Count
  • ELVN 5
  • FWRG 10
  • Target Price
  • ELVN $41.20
  • FWRG $22.20
  • AVG Volume (30 Days)
  • ELVN 487.3K
  • FWRG 1.1M
  • Earning Date
  • ELVN 11-12-2025
  • FWRG 11-06-2025
  • Dividend Yield
  • ELVN N/A
  • FWRG N/A
  • EPS Growth
  • ELVN N/A
  • FWRG N/A
  • EPS
  • ELVN N/A
  • FWRG 0.06
  • Revenue
  • ELVN N/A
  • FWRG $1,105,027,000.00
  • Revenue This Year
  • ELVN N/A
  • FWRG $22.16
  • Revenue Next Year
  • ELVN $25.00
  • FWRG $16.20
  • P/E Ratio
  • ELVN N/A
  • FWRG $281.99
  • Revenue Growth
  • ELVN N/A
  • FWRG 14.53
  • 52 Week Low
  • ELVN $13.30
  • FWRG $12.90
  • 52 Week High
  • ELVN $30.03
  • FWRG $22.71
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 38.66
  • FWRG 49.97
  • Support Level
  • ELVN $18.80
  • FWRG N/A
  • Resistance Level
  • ELVN $20.30
  • FWRG $17.83
  • Average True Range (ATR)
  • ELVN 1.09
  • FWRG 0.59
  • MACD
  • ELVN -0.18
  • FWRG -0.87
  • Stochastic Oscillator
  • ELVN 12.77
  • FWRG 85.87

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About FWRG First Watch Restaurant Group Inc.

First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.

Share on Social Networks: